[HTML][HTML] SHP2 drives adaptive resistance to ERK signaling inhibition in molecularly defined subsets of ERK-dependent tumors

TA Ahmed, C Adamopoulos, Z Karoulia, X Wu… - Cell reports, 2019 - cell.com
Pharmacologic targeting of components of ERK signaling in ERK-dependent tumors is often
limited by adaptive resistance, frequently mediated by feedback-activation of RTK signaling …

[HTML][HTML] SHP2 Drives Adaptive Resistance to ERK Signaling Inhibition in Molecularly Defined Subsets of ERK-Dependent Tumors

TA Ahmed, C Adamopoulos, Z Karoulia, X Wu… - Cell reports, 2019 - ncbi.nlm.nih.gov
Pharmacologic targeting of components of ERK signaling in ERK-dependent tumors is often
limited by adaptive resistance, frequently mediated by feedback-activation of RTK signaling …

[HTML][HTML] SHP2 Drives Adaptive Resistance to ERK Signaling Inhibition in Molecularly Defined Subsets of ERK-Dependent Tumors

TA Ahmed, C Adamopoulos, Z Karoulia, X Wu… - Cell Reports, 2019 - Elsevier
Pharmacologic targeting of components of ERK signaling in ERK-dependent tumors is often
limited by adaptive resistance, frequently mediated by feedback-activation of RTK signaling …

SHP2 Drives Adaptive Resistance to ERK Signaling Inhibition in Molecularly Defined Subsets of ERK-Dependent Tumors.

TA Ahmed, C Adamopoulos, Z Karoulia, X Wu… - Cell Reports, 2019 - europepmc.org
Pharmacologic targeting of components of ERK signaling in ERK-dependent tumors is often
limited by adaptive resistance, frequently mediated by feedback-activation of RTK signaling …

[引用][C] SHP2 Drives Adaptive Resistance to ERK Signaling Inhibition in Molecularly Defined Subsets of ERK-Dependent Tumors

TA Ahmed, C Adamopoulos, Z Karoulia, X Wu… - Cell Reports, 2019 - cir.nii.ac.jp
SHP2 Drives Adaptive Resistance to ERK Signaling Inhibition in Molecularly Defined
Subsets of ERK-Dependent Tumors | CiNii Research CiNii 国立情報学研究所 学術情報 …

SHP2 Drives Adaptive Resistance to ERK Signaling Inhibition in Molecularly Defined Subsets of ERK-Dependent Tumors

TA Ahmed, C Adamopoulos, Z Karoulia, X Wu… - Cell …, 2019 - pubmed.ncbi.nlm.nih.gov
Pharmacologic targeting of components of ERK signaling in ERK-dependent tumors is often
limited by adaptive resistance, frequently mediated by feedback-activation of RTK signaling …

SHP2 Drives Adaptive Resistance to ERK Signaling Inhibition in Molecularly Defined Subsets of ERK-Dependent Tumors.

TA Ahmed, C Adamopoulos, Z Karoulia, X Wu… - Cell Reports, 2019 - europepmc.org
Pharmacologic targeting of components of ERK signaling in ERK-dependent tumors is often
limited by adaptive resistance, frequently mediated by feedback-activation of RTK signaling …